Skip to main content

Advertisement

Log in

Impact of dehydroepiandrosterone on thyroid autoimmunity and function in men with autoimmune hypothyroidism

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Testosterone administration was found to have a protective effect on thyroid autoimmunity in men with autoimmune (Hashimoto’s) thyroiditis. Objective The present study was aimed at assessing whether oral dehydroepiandrosterone affects thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity in men with subclinical hypothyroidism induced by Hashimoto’s thyroiditis. Setting The study was conducted at Medical University of Silesia, Katowice, Poland. Method The study enrolled 32 elderly men with autoimmune hypothyroidism and low dehydroepiandrosterone-sulfate levels. Based on patient preference, the participants either received oral dehydroepiandrosterone (50 mg daily; n = 16) or remained untreated (n = 16). Apart from measuring antibody titers and hormone levels, we calculated baseline and post-treatment values of three structure parameters of thyroid homeostasis. Main outcome measure Serum titers of thyroid peroxidase and thyroglobulin antibodies. Results At baseline, there were no significant differences in the investigated parameters between both groups of men. All participants completed the study. Oral dehydroepiandrosterone increased dehydroepiandrosterone-sulfate and testosterone levels, as well as had a neutral effect on estradiol levels. The increase in dehydroepiandrosterone-sulfate correlated with treatment-induced changes in serum testosterone. Moreover, dehydroepiandrosterone reduced titers of thyroid peroxidase and thyroglobulin antibodies, decreased serum thyrotropin levels, reduced Jostel’s thyrotropin index as well as increased thyroid’s secretory capacity. Treatment-induced changes in thyroid antibody titers, thyrotropin levels, Jostel’s thyrotropin index and thyroid’s secretory capacity correlated with the increase in dehydroepiandrosterone-sulfate and testosterone levels. Conclusion The obtained results show that exogenous dehydroepiandrosterone may exert a beneficial effect on thyroid autoimmunity and hypothalamic-pituitary-thyroid axis activity in men with autoimmune thyroiditis and subclinical hypothyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. Risky drinking was defined as alcohol consumption exceeding 14 standard drinks per week or 4 standard drinks per day; binge drinking was defined as five or more standard drinks on a single occasion; while a standard drink was defined as one 12-oz bottle of beer, one 5-oz glass of wine, or 1.5 oz of distilled spirits.

  2. Aminoglutethimide, amiodarone, anabolic steroids, antithyroid agents, bexarotene, cholecalciferol and its analogs, cholestyramine, colestipol, dopamine, estrogens, fluorouracil, furosemide, glucocorticoids, interferon-α, interleukin-2, iodides, lithium, methadone, mitotane, myo-inositol, nonsteroidal anti-inflammatory drugs, octreotide, perchlorates, salicylates, selenium, slow-release nicotinic acid or tamoxifen.

Abbreviations

CI:

Confidence interval

DHEA:

Dehydroepiandrosterone

DHEA-S:

Dehydroepiandrosterone-sulfate

IU:

International unit

SD:

Standard deviation

SPINA:

Structure parameter inference approach

TgAb:

Thyroglobulin antibodies

TPOAb:

Thyroid peroxidase antibodies

References

  1. Caturegli P, Kimura H, Rocchi R, Rose NR. Autoimmune thyroid diseases. Curr Opin Rheumatol. 2007;19:44–8.

    Article  Google Scholar 

  2. Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr. 2009;21:523–8.

    Article  Google Scholar 

  3. Chen Y, Chen Y, Xia F, Wang N, Chen C, Nie X, et al. A higher ratio of estradiol to testosterone is associated with autoimmune thyroid disease in males. Thyroid. 2017;27:960–6.

    Article  CAS  Google Scholar 

  4. Wortsman J, Rosner W, Dufau ML. Abnormal testicular function in men with primary hypothyroidism. Am J Med. 1987;82:207–12.

    Article  CAS  Google Scholar 

  5. Doukas C, Saltiki K, Mantzou A, Cimponeriu A, Terzidis K, Sarika L, et al. Hormonal parameters and sex hormone receptor gene polymorphisms in men with autoimmune diseases. Rheumatol Int. 2013;34:575–82.

    Article  Google Scholar 

  6. Krysiak R, Kowalcze K, Okopień B. The effect of testosterone on thyroid autoimmunity in euthyroid men with Hashimoto’s thyroiditis and low testosterone levels. J Clin Pharm Ther. 2019;44:742–9.

    Article  CAS  Google Scholar 

  7. Krysiak R, Kowalcze K, Okopień B. The effect of spironolactone onthyroidautoimmunity in euthyroid men with Hashimoto’s thyroiditis. J Clin Pharm Ther. 2020;45:152–9.

    Article  CAS  Google Scholar 

  8. Prall SP, Muehlenbein MP. DHEA modulates immune function: a review of evidence. Vitam Horm. 2018;108:125–44.

    Article  CAS  Google Scholar 

  9. Drbalová K, Matucha P, Matejková-Behanová M, Bílek R, Kríz L, Kazihnitková H, et al. Immunoprotective steroids and SHBG in non-treated hypothyroidism and their relationship to autoimmune thyroid disorders. Physiol Res. 2008;57(Suppl 1):S119–25.

    Article  Google Scholar 

  10. Ott J, Pecnik P, Promberger R, Pils S, Seemann R, Hermann M, et al. Dehydroepiandrosterone in women with premature ovarian failure and Hashimoto’s thyroiditis. Climacteric. 2014;17:92–6.

    Article  CAS  Google Scholar 

  11. Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index. Clin Endocrinol. 2009;71:529–34.

    Article  CAS  Google Scholar 

  12. Dietrich JW, Landgrafe-Mende G, Wiora E, Chatzitomaris A, Klein HH, Midgley JE, et al. Calculated parameters of thyroid homeostasis: emerging tools for differential diagnosis and clinical research. Front Endocrinol. 2016;7:57.

    Article  Google Scholar 

  13. Dietrich JW, Müller P, Schiedat F, Schlömicher M, Strauch J, Chatzitomaris A, et al. Nonthyroidal illness syndrome in cardiac illness involves elevated concentrations of 3,5-diiodothyronine and correlates with atrial remodeling. Eur Thyroid J. 2015;4:129–37.

    Article  CAS  Google Scholar 

  14. Merrill SJ, Minucci SB. Thyroid autoimmunity: an interplay of factors. Vitam Horm. 2018;106:129–45.

    Article  CAS  Google Scholar 

  15. Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 2002;12:839–47.

    Article  Google Scholar 

  16. Colucci P, Yue CS, Ducharme M, Benvenga S. A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism. Eur Endocrinol. 2013;9:40–7.

    Article  Google Scholar 

  17. Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35:433–512.

    Article  CAS  Google Scholar 

  18. Papierska L, Rabijewski M. Delay in diagnosis of adrenal insufficiency is a frequent cause of adrenal crisis. Int J Endocrinol. 2013;2013:482370.

    Article  Google Scholar 

  19. Papi G, Uberti ED, Betterle C, Carani C, Pearce EN, Braverman LE, et al. Subclinical hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2007;14:197–208.

    Article  Google Scholar 

  20. Floriani C, Gencer B, Collet TH, Rodondi N. Eur Heart J. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. 2018;39:503–7.

  21. Webb SJ, Geoghegan TE, Prough RA, Miller MK. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev. 2006;38:89–116.

    Article  CAS  Google Scholar 

  22. Pelletier G. Localization of androgen and estrogen receptors in rat and primate tissues. Histol Histopathol. 2000;15:1261–70.

    CAS  PubMed  Google Scholar 

  23. Gessl A, Lemmens-Gruber R, Kautzky-Willer A. Thyroid disorders. Handb Exp Pharmacol. 2012;214:361–86.

    Article  CAS  Google Scholar 

  24. Hildebrand F, Pape HC, Hoevel P, Krettek C, van Griensven M. The importance of systemic cytokines in the pathogenesis of polymicrobial sepsis and dehydroepiandrosterone treatment in a rodent model. Shock. 2003;20:338–46.

    Article  CAS  Google Scholar 

  25. Powell JM, Sonnenfeld G. The effects of dehydroepiandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production. J Interferon Cytokine Res. 2006;26:34–9.

    Article  CAS  Google Scholar 

  26. Krysiak R, Okopień B. The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 2011;96:2206–15.

    Article  CAS  Google Scholar 

  27. Kłapcińska B, Poprzecki S, Danch A, Sobczak A, Kempa K. Selenium levels in blood of Upper Silesian population: evidence of suboptimal selenium status in a significant percentage of the population. Biol Trace Elem Res. 2005;108:1–15.

    Article  Google Scholar 

  28. Szybiński Z. Polish council for control of iodine deficiency disorders. Work of the Polish council for control of iodine deficiency disorders, and the model of iodine prophylaxis in Poland. Endokrynol Pol. 2012;63:156–60.

    PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Ewa Zmuda, a professional translator, for English language editing.

Funding

This work was not supported by any external source of funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Krysiak.

Ethics declarations

Conflicts of interest

The authors declare they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krysiak, R., Szkróbka, W. & Okopień, B. Impact of dehydroepiandrosterone on thyroid autoimmunity and function in men with autoimmune hypothyroidism. Int J Clin Pharm 43, 998–1005 (2021). https://doi.org/10.1007/s11096-020-01207-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-020-01207-w

Keywords

Navigation